Miller JL - Search Results

1

Impact of Ceftazidime Use on Susceptibility Patterns in the Neonatal Intensive Care Unit.

Miller JL, Johnson PN, White BP, Neely SB, Chaaban H, Kassa N, Welliver RC Sr. Miller JL, et al. Pediatr Infect Dis J. 2019 Jun;38(6):605-607. doi: 10.1097/INF.0000000000002255. Pediatr Infect Dis J. 2019. PMID: 30489466

2

Effectiveness of trimethoprim/sulfamethoxazole for children with chronic active otitis media.

Miller JL, Honey BL, Johnson PN, Hagemann TM. Miller JL, et al. Pediatrics. 2007 Dec;120(6):1403; author reply 1403-4. doi: 10.1542/peds.2007-2543. Pediatrics. 2007. PMID: 18055693 No abstract available.

3

Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients.

Honey BL, Benefield RJ, Miller JL, Johnson PN. Honey BL, et al. Among authors: miller jl. Ann Pharmacother. 2009 Sep;43(9):1506-11. doi: 10.1345/aph.1M161. Epub 2009 Aug 18. Ann Pharmacother. 2009. PMID: 19690220 Review.

4

Pantoprazole-induced thrombocytopenia.

Miller JL, Gormley AK, Johnson PN. Miller JL, et al. Indian J Pediatr. 2009 Dec;76(12):1278-9. doi: 10.1007/s12098-009-0224-9. Indian J Pediatr. 2009. PMID: 20012806 No abstract available.

5

Evaluation of inpatient admissions and potential antimicrobial and analgesic dosing errors in overweight children.

Miller JL, Johnson PN, Harrison DL, Hagemann TM. Miller JL, et al. Ann Pharmacother. 2010 Jan;44(1):35-42. doi: 10.1345/aph.1M371. Epub 2009 Dec 22. Ann Pharmacother. 2010. PMID: 20028958

6

Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.

Gish EC, Miller JL, Honey BL, Johnson PN. Gish EC, et al. Among authors: miller jl. Ann Pharmacother. 2010 Feb;44(2):343-51. doi: 10.1345/aph.1M347. Epub 2009 Dec 29. Ann Pharmacother. 2010. PMID: 20040696 Review.

7

Continuous-infusion neuromuscular blocking agents in critically ill neonates and children.

Johnson PN, Miller J, Gormley AK. Johnson PN, et al. Pharmacotherapy. 2011 Jun;31(6):609-20. doi: 10.1592/phco.31.6.609. Pharmacotherapy. 2011. PMID: 21923445 Review.

8

Vancomycin dosage in overweight and obese children.

Miller M, Miller JL, Hagemann TM, Harrison D, Chavez-Bueno S, Johnson PN. Miller M, et al. Among authors: miller jl. Am J Health Syst Pharm. 2011 Nov 1;68(21):2062-8. doi: 10.2146/ajhp110107. Am J Health Syst Pharm. 2011. PMID: 22011985

9

A pilot study assessing the frequency and complexity of methadone tapers for opioid abstinence syndrome in children discharged to home.

Johnson PN, Harrison DL, Castro CH, Miller JL. Johnson PN, et al. Among authors: miller jl. Res Social Adm Pharm. 2012 Sep-Oct;8(5):455-63. doi: 10.1016/j.sapharm.2011.12.002. Epub 2012 Jan 4. Res Social Adm Pharm. 2012. PMID: 22222345

10

Selection of the initial methadone regimen for the management of iatrogenic opioid abstinence syndrome in critically ill children.

Johnson PN, Boyles KA, Miller JL. Johnson PN, et al. Among authors: miller jl. Pharmacotherapy. 2012 Feb;32(2):148-57. doi: 10.1002/PHAR.1001. Epub 2012 Jan 24. Pharmacotherapy. 2012. PMID: 22392424 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,142 results

Search Page

Filters